US$ 26.33
surmount-1 tirzepatide weight loss percent 72 weeks The New - SURMOUNT-1: In an RCT, adults with obesity treated with weekly had major over weeks. #ADA2022 https://nej.md/3mjAbvD I Was Right (and Wrong)
Description
Switching from Tirzepatide to Retatrutide may be possible once Retatrutide receives approval, but discuss this thoroughly with your healthcare provider first

Reevaluate your dose

GIP has been shown to decrease appetite and increase energy expenditure, which leads to weight loss
The hypothalamus, which orchestrates the stress response

Because of this effect, many patients also experience support with weight management
